Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Firefly Neuroscience, Inc. - Common Stock (NQ:AIFF)

0.7845 +0.0254 (+3.35%)
Streaming Delayed Price Updated: 12:15 PM EST, Feb 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Firefly Neuroscience, Inc. - Common Stock

< Previous 1 2 Next >
News headline image
Dow Gains Over 200 Points; Signet Jewelers Shares Plunge ↗
 
Via Benzinga
Topics Stocks
News headline image
Crude Oil Down 1%; Firefly Neuroscience Shares Spike Higher ↗
 
Via Benzinga
News headline image
What's Going On With Firefly Neuroscience Stock Tuesday? ↗
Firefly Neuroscience shares are trading higher on Tuesday after the company announced the advancement of research to assess a patient's brain age. 
Via Benzinga
News headline image
Nasdaq Jumps 150 Points; US Producer Prices Increase 0.2% In December ↗
 
Via Benzinga
News headline image
12 Information Technology Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Information Technology Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Information Technology Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
News headline image
12 Information Technology Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
Bright Minds Biosciences and Firefly Neuroscience to Collaborate After the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy for Full Analysis of EEG Data
From Bright Minds Biosciences
Via GlobeNewswire
News headline image
12 Information Technology Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
12 Information Technology Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
Firefly Neuroscience And Bright Minds Advance Phase 1 Study With AI-Driven Data Analysis ↗
Firefly Neuroscience partners with Bright Minds Biosciences to analyze positive Phase 1 data of BMB-101 using advanced AI technology, setting the stage for Phase 2 trials. 
Via Benzinga
Topics Artificial Intelligence
News headline image
12 Information Technology Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Information Technology Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.